Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002771 | Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | unknown | Phase 3 | 750 | German CML Study GroupOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00416377 | Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | unknown | N/A | 353 | Children's Cancer and Leukaemia GroupOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00417014 | Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | unknown | N/A | 358 | Children's Cancer and Leukaemia GroupOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | unknown | Phase 2 | 25 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00893477 | GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | unknown | Phase 2 | 60 | French Innovative Leukemia OrganisationOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00896519 | GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma | unknown | Phase 2 | 30 | French Innovative Leukemia OrganisationOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00907036 | Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma | unknown | Phase 2 | 49 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | unknown | Phase 2 | 47 | Cancer Research UKOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT01914744 | Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | unknown | Phase 2 | 82 | Fudan UniversityOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01728389 | Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. | unknown | Phase 1 / Phase 2 | 10 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01892852 | Acupuncture for Chemotherapy-induced Peripheral Neuropathy | unknown | N/A | 36 | Pusan National University HospitalOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01901666 | Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission | unknown | Phase 4 | 20 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01421862 | Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment | unknown | — | 400 | National Cancer Institute (NCI)NIH | 0 | Jul 10, 2013 | clinicaltrials |
| NCT01653613 | Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | unknown | — | 400 | Eastern Cooperative Oncology GroupNETWORK | 0 | Jul 10, 2013 | clinicaltrials |
| NCT01894945 | Dual Time Point PET in Lymphoma | unknown | — | 30 | Odense University HospitalOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01891578 | Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation | unknown | — | 23 | Armando Santoro, MDOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01887561 | Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial | unknown | Phase 2 | 100 | Kanto CML Study GroupOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT01880918 | A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing | unknown | — | 200 | novoGIINDUSTRY | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01868828 | A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma | unknown | Phase 4 | 50 | Peking University People's HospitalOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT01695590 | Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 40 | Prolexys PharmaceuticalsINDUSTRY | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01488591 | Biomarker Research for Personalized Medicine | unknown | — | 1,000 | Inje UniversityOTHER | 1 | May 31, 2013 | clinicaltrials |
| NCT01865058 | The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma. | unknown | — | 50 | Odense University HospitalOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01859234 | 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma | unknown | N/A | 20 | University Medical Center GroningenOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT01849939 | Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia(RICAC) | unknown | Phase 2 | 43 | University Hospital, Clermont-FerrandOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00930566 | Extracorporal Photopheresis Pilot Study(ECP) | unknown | Phase 1 / Phase 2 | 20 | Hospices Civils de LyonOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01830478 | Lenalidomide Plus Rituximab (R) in Non Follicular NHL | unknown | Phase 2 | 44 | Gruppo Italiano Studio LinfomiOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01503502 | A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | unknown | Phase 2 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01828008 | Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas(CIK) | unknown | — | 20 | Han weidongOTHER | 0 | Apr 10, 2013 | clinicaltrials |
| NCT01828619 | Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients | unknown | — | 60 | Peking University People's HospitalOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01686386 | Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma | unknown | Phase 1 / Phase 2 | 60 | Gruppo Italiano Studio LinfomiOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01816022 | Myeloproliferative Neoplasms and Bone Structure | unknown | — | 125 | University of Southern DenmarkOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT01813344 | Hyper-CVAD Treatment in Lymphoblastic Lymphoma(LBL-CISL-1) | unknown | — | 50 | Ajou University School of MedicineOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01809392 | Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | unknown | Phase 2 / Phase 3 | 15 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT01278602 | R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01333605 | IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma | unknown | Phase 2 | 43 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01667302 | Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01804127 | Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL | unknown | Phase 2 | 196 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00636922 | Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia | unknown | Phase 1 | 40 | Bayside HealthOTHER_GOV | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01785953 | Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia(AML) | unknown | — | 300 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01780766 | Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging | unknown | — | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT01766375 | the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient(IDBUCY) | unknown | Phase 3 | 200 | Guangxi Medical UniversityOTHER | 1 | Jan 11, 2013 | clinicaltrials |
| NCT01716364 | Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome | unknown | Phase 1 | 6 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01678430 | A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment(RIAltO) | unknown | Phase 3 | 670 | University of LiverpoolOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01615757 | Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation(Ara-c) | unknown | Phase 3 | 180 | All India Institute of Medical SciencesOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00982514 | Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008 | unknown | — | 60 | Oslo University HospitalOTHER | 1 | Sep 12, 2012 | clinicaltrials |
| NCT00209222 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | unknown | Phase 3 | 360 | European Mantle Cell Lymphoma NetworkOTHER | 3 | Sep 10, 2012 | clinicaltrials |
| NCT01037556 | PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia | unknown | Phase 1 / Phase 2 | 50 | Proacta, IncorporatedINDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00397800 | Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 12 | Technical University of MunichOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT01670812 | Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia | unknown | Phase 3 | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2012 | clinicaltrials |
| NCT01665001 | Personalized Therapy of Precursor Lymphoid Neoplasms | unknown | Phase 2 | 200 | Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, GliwiceOTHER | 1 | Aug 17, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Aug 2, 2013source: clinicaltrials